MedPath

Shanghai Ovarian Cancer and Family Care Project

Recruiting
Conditions
Ovarian Cancer
Registration Number
NCT06118307
Lead Sponsor
Shanghai First Maternity and Infant Hospital
Brief Summary

Ovarian cancer is the most lethal gynaecological malignancy, but its incidence in the general population is low. Due to the lack of effective prevention and successful screening approaches, most cases are diagnosed at advanced stages, leading to poor prognosis. In order to address the research requirements pertaining to ovarian cancer, the Shanghai Ovarian Cancer and Family Care Project was established. This initiative offers hospital-based resources for investigating ovarian cancer and high-risk populations. The project comprises an on-going ovarian cancer cohort, a high-risk population cohort, and a healthy population cohort. By leveraging these comprehensive cohorts, the project provides a unique platform for in-depth studies on the detection, prevention, early diagnosis, treatment, and prognosis of ovarian cancer.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
Female
Target Recruitment
3546
Inclusion Criteria

Not provided

Read More
Exclusion Criteria
  • Individuals with evidence of another active cancer.
  • Individuals who have prior bilateral oophorectomy.
  • Individuals who are unwilling or unable to sign the informed consent form.
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Death due to ovarian cancerFrom diagnosis of ovarian cancer until October 31, 2028.

Death due to ovarian cancer determined by independent outcomes committee.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Shanghai first maternity and infant hospital

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath